| Collaborative Research Center TRR 57 | |||
![]() |
Weitere Informationen auf der externen Webseite: www.sfbtrr57.rwth-aachen.de*
___________________________________________ |
![]() |
|
![]() | |||
![]() |
P01: Identification and characterisation of complement factor C5 as quantitative trait gene that modifies liver fibrogenesis in mono- and polygenic mouse models P02: Functional and structural characterisation of the PKHD1 protein polyductin in the etiology of liver fibrosis P03: Collagen gene regulation in patients with progressive organ fibrosis due to diabetic nephropathy or IgA nephritis P04: The role of E-type cyclins and G1-S phase cell cycle transition in initiation and progression of murine liver fibrosis P05: The impact of the LIM domain proteins FHL2 and CRP2 on hepatic stellate cell activation and its crosstalk with TGF- signalling pathways in hepatic fibrogenesis P06: The role of the NF- B signalling pathway in liver fibrosis P07: The molecular mechanism of MIF and CXCR2 in liver fibrosis - analysis of the MIF/CXCR2 axis and the MIF/JAB1/Smad signalling pathway P08: The CXCR3/CXCL9 chemokine system as an antifibrotic target in murine liver fibrosis P09: Role of monocyte subsets in liver fibrogenesis P10: Role of dendritic cells in immune-mediated glomerular damage and renal fibrosis P11: Role of liver antigen presenting cell immune function in liver fibrosis P12: Regulation of natural killer cells by CC chemokines as a pivotal factor of hepatic fibrogenesis in viral hepatitis P13: Exogenous and endogenous modulators of PDGF/TGF- signalling in liver fibrogenesis and their therapeutic application P14: Molecular mechanisms of renal fibrosis: analysis of the pathophysiological role of Platelet Derived Growth Factor-C (PDGF-C) P15: The role of endocannabinoids in hepatic injury and fibrosis P16: Defining c-Met-dependent cellular interactions in a mouse model of hepatocyte transplantation P17: Prevention of renal fibrosis by replacing podocytes P18: Angiotensin-stimulated hepatic fibrogenesis and portal hypertension: Receptor regulation and intracellular signalling P19: Mesenchymal stem cells in renal fibrosis: Benefits and risks Q1: Histopathological analysis and quantification of hepatic and renal fibrosis Q2: Central animal resource project Q3: FACS-based cell sorting of parenchymal and non-parenchymal cells from liver and kidney Z: Administrative Project |
![]() |
|
![]() | |||
![]() |
Participating university departments and institutes University of Bonn Saarland University University of Heidelberg |
![]() |
|
![]() | |||